These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6990285

  • 1. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R, Vetter H, Kramer HJ.
    Nephron; 1980; 25(4):187-92. PubMed ID: 6990285
    [No Abstract] [Full Text] [Related]

  • 2. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 3. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1367-73. PubMed ID: 7004464
    [Abstract] [Full Text] [Related]

  • 4. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly.
    Moore TJ, Thein-Wai W, Dluhy RG, Dawson-Hughes BF, Hollenberg NK, Williams GH.
    J Clin Endocrinol Metab; 1980 Aug 15; 51(2):215-22. PubMed ID: 6995474
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
    Vetter W, Vetter H, Beckerhoff R, Redlich B, Cottier P, Siegenthaler W.
    Klin Wochenschr; 1976 Jul 15; 54(14):661-3. PubMed ID: 979066
    [Abstract] [Full Text] [Related]

  • 9. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Jul 15; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 10. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.
    Hata T, Ogihara T, Mikami H, Nakamaru M, Mandai T, Kumahara Y.
    Eur J Clin Pharmacol; 1980 Oct 15; 18(4):295-9. PubMed ID: 7002566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of an angiotensin antagonist on blood pressure, renin and aldosterone secretion and its pathogenetic importance].
    Beckerhoff R.
    Schweiz Med Wochenschr Suppl; 1978 Oct 15; (7):1-24. PubMed ID: 349683
    [No Abstract] [Full Text] [Related]

  • 13. Saralasin (1-sar-8-ala-angiotensin II): pharmacology and clinical use in angiotensin-dependent hypertension.
    Streeten DH, Castellian AW, Micalizzi ER, Dalakos TG, Anderson GH, Freiberg JM, Keenan RE.
    Contrib Nephrol; 1976 Oct 15; 3():52-70. PubMed ID: 1026370
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intrarenal control of electrolyte excretion by angiotensin II.
    Hall JE, Guyton AC, Trippodo NC, Lohmeier TE, McCaa RE, Cowley AW.
    Am J Physiol; 1977 Jun 15; 232(6):F538-44. PubMed ID: 879288
    [No Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH, Tan SY, Mulrow PJ.
    J Clin Endocrinol Metab; 1977 Jul 15; 45(1):10-5. PubMed ID: 874056
    [Abstract] [Full Text] [Related]

  • 17. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
    Dalakos TG, Elias AN, Anderson GH, Streeten DH, Schroeder ET.
    J Clin Endocrinol Metab; 1978 Jan 15; 46(1):114-8. PubMed ID: 752014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET, Anderson GH, Goldman SH, Streeten DH.
    Kidney Int; 1976 Jun 15; 9(6):511-9. PubMed ID: 940284
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and experimental studies on the angiotensin inhibitor 1-sar-8-ile-angiotensin II (P 165)].
    Werner U, Waelsch I, Bock KD.
    Verh Dtsch Ges Inn Med; 1976 Jun 15; 82 Pt 2():1310-3. PubMed ID: 1029986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.